Annovis Bio, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ANVS | ALEC | VYGR | LONA | ALGS | ABVC | |
|---|---|---|---|---|---|---|
| Market cap | 51.64M | 254.58M | 115.23M | 43.01M | 31.35M | 26.69M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -1.4 | -3.1 | -1.5 | — | -1.0 | -2.3 |
| Price/book | -12.1 | -25.6 | 0.7 | 1.3 | 1.0 | 2.5 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −39.20% | +75.38% | −55.69% | +13.84% | −29.30% | −64.79% |
| Today | +11.01% | +11.22% | +2.19% | −4.30% | +5.68% | +1.51% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ANVS news ›Annovis Bio, Inc. Receives Continued Listing Standard Notice from the NYSE
MALVERN, Pa., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnol... Annovis Bio, Inc. Receives Continued Listing Standard Notice from the NYSE MALVERN, Pa.,…
Annovis Bio announces partnership with Weave Bio
Annovis Bio (ANVS) announced a collaboration with Weave Bio, an AI platform for regulatory content and knowledge management, in support of the p... Annovis Bio announces partnership with Weave Bio Annovis Bio (ANVS) announced a…
Annovis Bio receives noncompliance notification from Nasdaq
Annovis Bio (ANVS) announced that it received notice from the NYSE that it is no longer in compliance with the NYSE continued listing standards ... Annovis Bio receives noncompliance notification from Nasdaq Annovis Bio (ANVS) announced…
Annovis Bio Faces NYSE Delisting Risk Over Market Value
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) faces potential delisting from the New York Stock Exchange after its market capitalization fell below the exchange’s minimum threshold while the biotechnology company reported negative…
Annovis Bio (ANVS) Projected to Announce Quarterly Earnings on Wednesday
Posted by Kim Johansen on Nov 4th, 2026 Annovis Bio (NYSE:ANVS – Get Free Report) will likely be issuing its Q3 2026 resultson Wednesday, November 11th. Analysts expect Annovis Bio to announce earnings of ($0.30) per share for the quarter.…
Annovis Bio, Inc. Promotes Cheng Fang as Chief Scientific Officer
Annovis Bio, Inc. announced the promotion of Cheng Fang, Ph.D., to Chief Scientific Officer, effective July 01, 2026. Dr. Fang joined Annovis in 2021 and most recently served as Senior Vice President,... announced the promotion of Cheng…
Annovis Bio, Inc. Announces Partnership With Weave Bio In Preparation Of NDA For Buntanetap In Alzheimer?s Disease
Annovis Bio, Inc. announced a collaboration with Weave Bio, an AI platform for regulatory content and knowledge management, in support of the planned New Drug Application for buntanetap. Under the... announced a collaboration with Weave…
Certain Common Stock of Annovis Bio, Inc. are subject to a Lock-Up Agreement Ending on 17-AUG-2026.
These Common Stock will be under lockup for 90 days starting from 19-MAY-2026 to... Certain Common Stock of Annovis Bio, Inc are subject to a Lock-Up Agreement Ending on 17-AUG-2026
Annovis Bio corrects 2025 audit fees to $415,000, total fees $515,000
TradingView Annovis Bio corrects 2025 audit fees to $415,000, total fees $515,000 Annovis Bio corrected audit fee disclosure, reporting $415,000 in 2025 audit fees and $515,000 total fees. - Filed Form 8-K to correct typographica
More from 1 other outlet
Annovis to Attend the CTAD 2026 with Three Presentations
MALVERN, Pa., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnol... Annovis to Attend the CTAD 2026 with Three Presentations MALVERN, Pa., Oct. 22, 2026 (GLOBE…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com9
- markets.businessinsider.com4
- manilatimes.net1
- mychesco.com1
- stocktitan.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 18 articles, not a forecast.